- Home
- BYD vs RVMD Comparison
BYD vs RVMD Comparison
Compare BYD & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYD | RVMD |
|---|---|---|
| Founded | 1973 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 7.5B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BYD | RVMD |
|---|---|---|
| Price | $80.23 | $78.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $89.57 | $77.11 |
| AVG Volume (30 Days) | 722.3K | ★ 2.3M |
| Earning Date | 10-23-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | ★ 325.66 | N/A |
| EPS | ★ 22.22 | N/A |
| Revenue | ★ $4,070,839,000.00 | N/A |
| Revenue This Year | $2.59 | N/A |
| Revenue Next Year | N/A | $714.50 |
| P/E Ratio | $3.59 | ★ N/A |
| Revenue Growth | ★ 5.91 | N/A |
| 52 Week Low | $58.94 | $29.17 |
| 52 Week High | $88.49 | $81.33 |
Technical Indicators
Market Signals| Indicator | BYD | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 73.36 |
| Support Level | $81.62 | $74.52 |
| Resistance Level | $82.89 | $81.49 |
| Average True Range (ATR) | 1.55 | 2.56 |
| MACD | -0.06 | -0.12 |
| Stochastic Oscillator | 36.46 | 72.73 |
Price Performance
Historical ComparisonAbout BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.